Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.1.1 EX-3.1.1
- 3.1.2 EX-3.1.2
- 3.2.1 EX-3.2.1
- 3.2.2 EX-3.2.2
- 3.3.1 EX-3.3.1
- 3.3.2 EX-3.3.2
- 3.3.3 EX-3.3.3
- 3.4.1 EX-3.4.1
- 3.4.2 EX-3.4.2
- 3.5.1 EX-3.5.1
- 3.5.2 EX-3.5.2
- 3.5.3 EX-3.5.3
- 3.5.4 EX-3.5.4
- 3.6.1 EX-3.6.1
- 3.6.2 EX-3.6.2
- 3.6.3 EX-3.6.3
- 3.7.1 EX-3.7.1
- 3.7.2 EX-3.7.2
- 3.8.1 EX-3.8.1
- 3.8.2 EX-3.8.2
- 3.9.1 EX-3.9.1
- 3.9.2 EX-3.9.2
- 3.10.1 EX-3.10.1
- 3.10.2 EX-3.10.2
- 3.11.1 EX-3.11.1
- 3.11.2 EX-3.11.2
- 3.12 EX-3.12
- 4.1 EX-4.1
- 4.3 EX-4.3
- 4.4 EX-4.4
- 4.5 EX-4.5
- 4.6 EX-4.6
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 5.4 EX-5.4
- 5.5 EX-5.5
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.5 EX-10.5
- 10.6 EX-10.6
- 12.1 EX-12.1
- 21.1 EX-21.1
- 23.6 EX-23.6
- 23.7 EX-23.7
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
Grifols Therapeutics similar filings
Filing view
External links
Exhibit 12.1
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratio of earnings to fixed charges for each of the periods indicated using financial information prepared in accordance with IFRS.
Six months | Year Ended December 31, | |||||||||||||||||||||||
ended June 30, 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
(in thousands of Euros) | ||||||||||||||||||||||||
Computation of Fixed charges | ||||||||||||||||||||||||
Interest expense (1) | 55,546 | 49,660 | 27,087 | 29,305 | 23,523 | 20,263 | ||||||||||||||||||
Add: Interest capitalized | 260 | 2,399 | 1,278 | 0 | 0 | 0 | ||||||||||||||||||
Add: Estimated rental expenses (2) | 1,454 | 1,927 | 1,736 | 1,658 | 1,114 | 1,124 | ||||||||||||||||||
Add: Preference security dividend requirement | 0 | 0 | 0 | 0 | 0 | 21,877 | ||||||||||||||||||
Total Fixed Charges | 57,260 | 53,986 | 30,101 | 30,963 | 24,637 | 43,264 | ||||||||||||||||||
Computation of Earnings | ||||||||||||||||||||||||
Profit/(loss) before tax from continuing operations before share of profit or loss of associates | 89,580 | 158,663 | 203,943 | 172,245 | 123,568 | 63,433 | ||||||||||||||||||
Add: Fixed charges | 57,260 | 53,986 | 30,101 | 30,963 | 24,637 | 43,264 | ||||||||||||||||||
Add: Distributed earnings of associates | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||
Less: Preference security dividend requirement | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||||||||||
Total earnings | 146,840 | 212,649 | 234,044 | 203,208 | 148,205 | 106,697 | ||||||||||||||||||
Ratio of earnings to fixed charges | 2.5645 | 3.9390 | 7.7752 | 6.5629 | 6.0155 | 2.4662 |
Notes: | ||
(1) | Includes amortized premiums, discounts and capitalized expenses related to indebtedness. | |
(2) | Imputed interest on operating leases is estimated to be 10% of rental expense. |